Published in Alcohol Alcohol on March 22, 2001
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2008) 4.74
Drugs, HIV, and prisons. BMJ (1991) 4.52
Socioeconomic status, standard of living, and neurotic disorder. Lancet (1998) 3.80
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med (1999) 3.10
The Swiss heroin trials: testing alternative approaches. BMJ (1998) 3.00
Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry (2000) 2.91
The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. Psychol Med (1997) 2.74
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev (2003) 2.45
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
Britain's new strategy for tackling drugs misuse. Shows a welcome emphasis on evidence. BMJ (1998) 2.34
Socioeconomic inequalities in mortality among women and among men: an international study. Am J Public Health (1999) 2.31
HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. AIDS (1991) 2.30
Heroin overdose: the case for take-home naloxone. BMJ (1996) 2.25
Drug regimens that break a country's drug laws. BMJ (1993) 2.20
Alcoholics Anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev (2006) 2.18
Quality of systematic reviews used in guidelines for oncology practice. Ann Oncol (2006) 2.15
Metabolites formed during anaerobic transformation of toluene and o-xylene and their proposed relationship to the initial steps of toluene mineralization. Appl Environ Microbiol (1992) 2.10
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
Unequal access and unmet need: neurotic disorders and the use of primary care services. Psychol Med (2000) 2.08
Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med (2009) 2.06
Comorbidity of mental disorders with substance misuse. Br J Psychiatry (1997) 2.04
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant (2010) 2.00
Policy on drug misuse in Europe. BMJ (1994) 1.98
MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol (1998) 1.96
Harm minimisation for drug misusers. BMJ (1992) 1.91
Clinical features of patients attending a gender-identity clinic. Br J Psychiatry (1990) 1.82
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2003) 1.80
Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health (1991) 1.80
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2008) 1.79
Cognitive impairment in individuals currently using methamphetamine. Am J Addict (2000) 1.78
Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend (2001) 1.77
Individual and area-based indicators of socioeconomic status and childhood asthma. Eur Respir J (2003) 1.76
Role of small t antigen in the acute transforming activity of SV40. Cell (1982) 1.76
Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction (1998) 1.75
Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg (2007) 1.73
Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat (1997) 1.70
Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health (1999) 1.68
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity . Psychol Med (1998) 1.67
Neurotic disorders and the receipt of psychiatric treatment. Psychol Med (2000) 1.66
Analysis of the reliability and validity of the kinetic communicator exercise device. Med Sci Sports Exerc (1986) 1.65
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev (2004) 1.61
Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev (2004) 1.59
Use of the internet for self-education by patients with prostate cancer. Urology (2001) 1.57
Well users clinic for illicit drug users. BMJ (1989) 1.57
Nutritional survey of Bangladeshi children aged under 5 years in the London borough of Tower Hamlets. Arch Dis Child (1983) 1.56
Diagnosing addictive disease in chronic pain patients. Psychosomatics (1997) 1.55
Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav (1996) 1.54
Nipah virus infection among abattoir workers in Malaysia, 1998-1999. Int J Epidemiol (2001) 1.54
Misuse of temazepam. BMJ (1988) 1.51
An intensive outpatient approach for cocaine abuse treatment. The Matrix model. J Subst Abuse Treat (1995) 1.51
Suicide and overdose among opiate addicts. Addiction (1996) 1.51
Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-97. Addiction (2001) 1.50
Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative Study. Arch Gen Psychiatry (1983) 1.47
Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus? Schizophr Res (1995) 1.44
Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect (2006) 1.44
Use of an Exotic Carbon Source To Selectively Increase Metabolic Activity and Growth of Pseudomonas putida in Soil. Appl Environ Microbiol (1993) 1.43
LAAM maintenance vs methadone maintenance for heroin dependence. Cochrane Database Syst Rev (2002) 1.43
Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction (2000) 1.42
Treatment of partial losses of the helix. Plast Reconstr Surg (1998) 1.41
British psychiatric morbidity survey. Br J Psychiatry (1998) 1.40
Personalizing healthcare: from genetics through payment to improving care? J R Soc Med (2013) 1.40
Antidepressants for cocaine dependence. Cochrane Database Syst Rev (2001) 1.40
Management of the pregnant opiate user. Br J Hosp Med (1990) 1.39
Beyond platitudes: Problem drug use: a review of training. Br J Addict (1990) 1.38
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. QJM (2011) 1.38
Addiction medicine. JAMA (1996) 1.38
Socio-economic inequalities in mortality. Methodological problems illustrated with three examples from Europe. Rev Epidemiol Sante Publique (1998) 1.37
Methamphetamine and cocaine users: differences in characteristics and treatment retention. J Psychoactive Drugs (2000) 1.35
Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev (2004) 1.35
Substrate induction and metabolite accumulation during anaerobic toluene utilization by the denitrifying strain T1. Appl Environ Microbiol (1993) 1.35
The National Psychiatric Morbidity surveys of Great Britain--strategy and methods. Psychol Med (1997) 1.34
The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation. AAPS PharmSciTech (2009) 1.34
Fatal methadone and heroin overdoses: time trends in England and Wales. J Epidemiol Community Health (1997) 1.33
Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia (2010) 1.33
Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage. Drug Alcohol Depend (1998) 1.32
Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev (2006) 1.32
A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction (1999) 1.32
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry (2004) 1.26
Deaths attributable to methadone vs buprenorphine in France. JAMA (2001) 1.26
National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis (2000) 1.26
HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust (1997) 1.26
Debt, income and mental disorder in the general population. Psychol Med (2008) 1.24
Resection of the suprarenal inferior vena cava. The role of prosthetic replacement. Arch Surg (1995) 1.24
Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev (2006) 1.23
Surgical care in octogenarians. Br J Surg (1996) 1.22
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort. Neurology (2011) 1.22
Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol (2003) 1.22
Flavobacterium spp. organisms as opportunistic bacterial pathogens during advanced HIV disease. J Infect (1999) 1.21
Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev (2005) 1.21